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ABSTRACT
Objectives: The objective of this study was to estimate disease incidence and mortality rate of sepsis 
in a tertiary public hospital. Methods: Patients admitted to the Intensive Care Unit (ICU) in 2004 
and 2005 were monitored for sepsis using an observational longitudinal study design. Patients were 
monitored daily for diagnostic criteria of sepsis, according to ACCP/SCCM Consensus Conference 
criteria, until either death or hospital discharge. Results: During the study, we analyzed 1,179 pa-
tients. Systemic Inﬂ ammatory Response Syndrome (SIRS) was present in 1,048 (88.9%) patients on 
admission, and was associated with infection in 554 (47.0%) patients. Of these, sepsis was diagnosed 
in 30 (2.5%) patients, while severe sepsis was diagnosed in 269 (22.8%) patients, and septic shock 
was diagnosed in 255 (21.6%) patients. APACHE II and SOFA scores were higher in septic patients 
(p < 0.001), and the ensuing mortality rates were 32.8% (IC 95%: 21.6-45.7%) for patients with 
sepsis, 49.9% (IC 95%: 44.5-55.2%) for severe sepsis, and 72.7% (IC 95%: 68.1-76.9%) for septic 
shock. Conclusions: The data from our study revealed a high incidence of sepsis among hospitalized 
patients. Moreover, sepsis patients had a high rate of mortality.
Keywords: sepsis, incidence, mortality, epidemiology.
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INTRODUCTION 
Sepsis is a syndrome that affects the public 
health system and represents a challenge to 
health care providers and managers. Epidemio-
logical data revealed a high incidence of sepsis 
in patients hospitalized in Intensive Care Units 
(ICU) compared with the occurrence of disease 
in general population.1,2 Multicentre epidemio-
logic studies2-4 have applied sepsis defi nitions 
from the American College of Chest Physicians/
Society of Critical Care Medicine Consensus 
Conference5 to electronic hospital database 
records based on standardized diagnoses by 
International Coding Diagnosis classifi cation, 
and identifi ed a possible underestimation of 
sepsis incidence among hospitalized patients. 
Martin et al. evaluated these previous stud-
ies and estimated both high positive and high 
negative predictive values (97.7% and 80%, re-
spectively). The high negative predictive value 
resulted in 18.8% of sensibility; implying that 
four out of fi ve cases of severe sepsis in hospi-
talized patients were missed.1,3
Further complicating the monitoring ef-
fort, studies that applied consensus defini-
tions to identify the incidence of sepsis only 
considered patients admitted to the ICU5 and 
excluded sepsis patients admitted to other 
areas within the hospital. So, in fact, studies 
based on consensus defi nitions only reported 
the epidemiology of treated sepsis cases.
Worldwide, approximately 10% of pa-
tients admitted to the ICU presented with 
severe sepsis.1 In the United States, sepsis was 
responsible for 2.26% hospital admissions in 
1995, presenting an annual population inci-
dence of 3.0 per 1000 habitants.2 Thereafter, 
an 8.7% increase in annual incidence of sep-
sis was observed from 1979 through 2000, 
and the hospitalization rate due to severe 
sepsis nearly doubled from 1993 to 2003.3-4
Despite technological and therapeutic ad-
vances, mortality among sepsis patients re-
mains high, varying from 30% to 60%.6 In 
1995, an epidemiological study that included 
seven states in the United States identifi ed a 
28.6% mortality rate among sepsis patients, 
resulting in 215,000 deaths per year.2 More 
recently, an European study conducted in 198 
ICU in 24 countries showed 32.2% mortality at 
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60 days of follow-up of patients with severe sepsis and 54% 
mortality in patients with septic shock.7
The incidence of sepsis and mortality in patients with 
sepsis in Latin American is largely unknown.8,9 One study of 
patients in fi ve ICU from the south and southeast regions of 
Brazil reported an incidence density of 57.9 per 1000 patients-
day (CI 95%: 51.5-65.3), or 421 cases of sepsis resulting in 
30.5 per 100 ICU admissions.10 The authors described 241 
cases of severe sepsis and 203 cases of septic shock, resulting 
in 17.4 (CI 95%: 16.5-18.6) and 14.7 (CI 95%: 13.9-15.5) per 
100 ICU admissions, respectively. Mortality was higher in pa-
tients with severe sepsis (46.9%) and septic shock (52.2%), 
compared to sepsis (33.9%).10 Additional studies showed that 
the incidence and mortality of sepsis in Brazilians admitted to 
the ICU are among the highest in the world.6,11 Understand-
ing the reasons for the elevated incidence of sepsis in Brazil is 
the fi rst step to improving prevention, diagnosis, and care of 
septic patients in this country.
The objective of this study was to estimate the incidence 
of sepsis and associated mortality among diagnosed patients 
in the ICU of Londrina University Hospital. The study was 
conducted for two years, and the results were compared with 
similar studies documented in the literature.
 
METHODS
We used a prospective longitudinal study design with con-
secutive sampling of patients admitted to the ICU in Lond-
rina University Hospital (LUH). LUH is a teaching hospital 
with 330 beds, serving an estimated population of 825,000 
inhabitants. The study took place from January 1, 2004, to 
December 31, 2005. Exclusion criteria were (1) less than 18 
years of age, (2) less than 24 hours ICU length of stay, and 
(3) more than one ICU admission during the same hospi-
tal stay. During the fi rst 24 hours following admission, we 
collected demographic data, diagnoses on ICU admission 
and chronic diseases, according to the Acute Physiology and 
Chronic Health Evaluation II (APACHE II) score defi nitions. 
We also collected laboratory and clinical data for calculation 
of the APACHE II score, as originally described.12
Diagnostic criteria for Systemic Inﬂ ammatory Response 
Syndrome (SIRS), sepsis, severe sepsis, and septic shock were 
evaluated daily. Some patients were classifi ed into more than 
one diagnostic category during hospitalization because the 
diagnostic categories represent an evolution of sepsis. The 
stages of sepsis were diagnosed according to the American 
College of Chest Physicians/Society of Critical Care Medi-
cine Consensus Conference.5 SIRS was defi ned as the pres-
ence of two or more of the following criteria: temperature 
above 38° C or below 36° C; tachycardia (heart rate more 
than 90 beats/min); tachypnoea manifested by a raised res-
piratory rate (more than 20 breaths/min) or hyperventila-
tion (partial pressure of CO
2
 in arterial blood < 32 mmHg) 
or mechanical ventilation; or altered white blood cell count 
(more than 12,000/mm3, less than 4000/mm3 or more than 
10% of band forms). Sepsis was defi ned as the presence of 
infection associated with SIRS. If organ dysfunction resulted 
from sepsis, the case was defi ned as severe sepsis, and septic 
shock was defi ned when sepsis resulted in arterial hypoten-
sion needing vasopressors, despite initial volume resuscita-
tion. The onset of sepsis was considered the moment when 
screening and confi rmatory criteria were fi rst documented 
on patients’ records.
Organ dysfunction was evaluated daily, based on clinical 
and laboratory variables of the Sequential Organ Failure As-
sessment (SOFA), as previously described.13 Center for Dis-
ease Control and Prevention (CDC) criteria were applied to 
diagnose nosocomial infection.14 Infection site was defi ned 
by the attending physician and classifi ed as: pulmonary, ab-
dominal, urinary, blood, bone, skin/soft tissues, others, and 
undetermined. Diagnosis of community infection was done 
by the attending physician, based on clinical, laboratory, 
microbiologic variables, and image diagnostic methods.
Patients were stratifi ed into septic and non-septic groups 
for 28 days survival analysis. The non-septic group included 
patients classifi ed as non-SIRS, SIRS, and localized infection. 
The septic group included patients with sepsis, severe sepsis, 
or septic shock diagnosed anytime during their stay in ICU.
Patients presenting with more than one diagnosis of sep-
sis due to evolution of their septic state, were classifi ed ac-
cording to the most severe form at clinical presentation.
Data were collected until either death or ICU discharge, 
or at 28 days of ICU stay. Survival rates were established for 
patients discharged before 28 days by monitoring for subse-
quent hospitalizations, and by ambulatory consultations or 
phone calls.
Data collection was standardized and performed by the 
main investigator and trained subinvestigators. Sources of 
data were patient hospital records and the electronic hospi-
tal database. EpiInfo 3.3.2 version, Centers for Disease Con-
trol (CDC, Atlanta, GA), was used to store collected data. 
Data entry was standardized and errors or out of range val-
ues were checked.
The study was approved by the local Ethics Committee 
and informed patient consent was waived.
 
STATISTICAL ANALYSIS
Sample size calculation15 of 1,520 patients for longitudinal 
studies was performed using the Epitable program from 
EpiInfo, 6.04b version (CDC), considering the infi nite size of 
the population: 45% expected frequency of septic patients,10 
2.5% error margin and 95% confi dence interval.
Continuous variables with normal distribution were 
expressed as mean and standard deviation, and with non-
normal distribution as median and interquatiles. Categori-
cal variables were expressed as proportions. Descriptive sta-
tistics were applied to describe all relevant variables.
Kauss, Grion, Cardoso et al.
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Bivariate analysis was applied to compare septic and non-
septic groups. Student’s t test or nonparametric equivalent 
(Mann-Whitney) tests for non normal distribution were used 
to compare continuous variables. Proportions of categorical 
variables were compared using Pearson chi-square test.
Survival probabilities were estimated for septic and non-
septic patients using the Kaplan-Meier method. The log-
rank test was applied to compare survival times of the two 
independent groups of patients.
A signifi cance level of 5% was adopted and statistical 
analyses were performed with EpiInfo 3.3.2 version, (CDC), 




During the study period, 1,694 patients were admitted to the 
ICU. Of these, 38 were excluded from analysis because they 
were younger than 18 years of age, 346 were excluded for 
staying in the ICU less than 24 hours, 109 were excluded for 
more than one admission to the ICU, and 22 were excluded 
because of insuffi cient data. A total of 1,179 patients were 
analyzed (Figure 1).
Patients admitted to the ICU were predominately male 
(57.1%) and the median age was 59 (42-72) years. Most admis-
sions were for clinical treatment (70.1%), followed by elective 
surgeries (24.7%), and emergency surgeries (5.2%). Original 
hospital location assignments by department were the emer-
gency department (48%), followed by the operating room 
(29.9%), and wards (22.1%). The most frequent diagnoses 
on ICU admission were sepsis (40.3%), neurological diseases 
(5.2%), coronary artery disease (4.7%), postoperative period of 
gastrointestinal surgery (4.0%), and intracranial hemorrhage 
(3.8%). Chronic disease diagnosis, according to APACHE II 
defi nitions, was present in 159 (13.5%) patients, and immuno-
suppression was the most frequently diagnosed disease.
Median ICU length of stay was 4 (2-9) days, and hos-
pital length of stay was 16 (9-32) days. Median APACHE II 
score for all patients was 21 (13-28). Non-survivor patients 
had a median APACHE II score that was signifi cantly higher 
(27; IQ: 20–33) than survivors (16; IQ: 11-23) (p < 0.001). 
The median SOFA score on ICU admission was 6 (3-9) and 
was signifi cantly higher for non-survivors (median = 8; 
IQ: 6-11), as compared to survivors (median = 4; IQ: 2-7) 
(p < 0.001). Mortality at 28 days of follow-up was 42.2% (CI 
95%: 39.3%-45%).
On ICU admission, 131 patients (11.1%) did not present with 
SIRS criteria and 10 (0.8%) of these patients had localized infec-
tion. SIRS criteria were present in 1,048 patients (88.9%), among 
whom 554 (47%) had an associated infection focus. Among these 
554 patients, we recorded sepsis in 30 (2.5%), severe sepsis in 269 
(22.8%), and septic shock in 255 (21.6%) (Figure 1). The median 
APACHE II score was 13 (10-18) for patients without SIRS; 16 
(11-23) for those with SIRS but without infection; 19 (10-27) for 
patients with localized infection; 22 (13-27) for sepsis; 23 (17-28) 
for severe sepsis; and 30 (26-36) for patients with septic shock. 
The median SOFA on ICU admission was 4 (2-6) for patients 
without SIRS; 4 (2-7) for SIRS without infection; 6 (3-7) for lo-
calized infection; 4.5 (2-8) for sepsis; 6.0 (4-8) for severe sepsis; 
and 10 (9-12) for patients with septic shock.
Patients were systematically evaluated using diagnostic 
criteria throughout the ICU stay. The evaluation revealed 28 
(2.4%) patients with localized infection, 64 (5.4%) with sep-
sis, 353 (29.9%) with severe sepsis, and 412 (34.9%) with sep-
tic shock. Patients were classifi ed in more than one diagnostic 
category if they presented with worsening of clinical condition. 
The most frequent infection site was pulmonary (66.5%), fol-
lowed by the urinary system (13.6%), abdomen (6.6%), skin/
soft tissues (4.4%), and others (8.9%). Infection was classifi ed as 
community acquired in 291 (32.4%) cases, nosocomial in 300 
(33.4%) cases, and ICU acquired in 308 (34.3%) cases. Among 
712 patients with infection, 168 (23.6%) presented with more 
than one infection site. The mortality rates were 35.7% (CI 95%: 
18.6-55.9%) for patients with infection, 32.8% (CI 95%: 21.6-
45.7%) for patients with sepsis, 49.9% (CI 95%: 44.5-55.2%) for 
patients with severe sepsis, and 72.7% (IC 95%: 68.1-76.9%) for 
septic shock patients. Figure 2 describes patients according to 
the 28 day outcome and sepsis diagnoses classifi cation (sepsis, 
severe sepsis, and septic shock).
Figure 1: Fluxogram of patients analyzed in the study and 
diagnoses (n and %) on admission according to International 
Consensus Conference definitions.
Figure 2: Mortality rate (%) according to sepsis diagnostic 
criteria.
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Patients were stratifi ed into septic (697; 59.1%) and non-
septic (482; 40.9%) groups, based on only one diagnostic 
category for each patient. Among septic patients, 48 (6.9%) 
were classifi ed as sepsis, 353 (50.6%) as severe sepsis, and 
296 (42.5%) as septic shock patients. Males were predomi-
nant among septic patients (60.0%), compared to non-septic 
(52.9%) (p = 0.015). Septic patients were also older (62; 43-
74 years) compared to non-septic patients (56; 41-68 years) 
(p < 0.001). Most septic patients were admitted for clinical 
therapeutic procedures (83.4%), while 51.0% of non-septic 
patients were clinical admissions (Table 1).
Surviving septic patients had a median ICU length 
of stay of 8 (4-18) days, while non-septic patients had a 
shorter stay in ICU (median = 2 days; IQ: 2-3 days) (p 
< 0,001). Septic patients also remained in the hospital 
longer (median = 27 days; IQ: 16-48 days) compared to 
non-septic patients (median = 15 days; IQ: 9-27 days) 
(p < 0.001) (Table 2). Chronic disease was more frequent 
among septic patients (p < 0.001), and APACHE II scores 
were higher in septic patients compared to non-septic pa-
tients (p < 0.001).
Organ dysfunction in both groups was evaluated by 
SOFA score. We applied SOFA on the fi rst day of sepsis for 
septic patients and on the fi rst day of ICU admission for 
non-septic patients. SOFA scores were higher for septic pa-
tients (median = 8; IQ: 6-10) as compared to non-septic 
Kauss, Grion, Cardoso et al.
Table 1. General characteristics of septic and non-septic patients
             Variables                          Non-septic                 Septic  p-value
                          (n = 482)                   (n = 697)  
Male (n and %) 255 52.9 418 60.0 0.015*
Age (years)           
 Mean and standard deviation 54.6 18.0 58.1 19.6 < 0.001†
 Median (Interquartile) 56 41-68 62 43-74 < 0.001‡
Type of admission (n and %)         
 Medical 246 51.0 581 83.4 < 0.001*
 Surgical 236 49.0 116 16.6 < 0.001*
  Elective  216 44.9 75 10.7 < 0.001*
  Urgency  20 4.1 41 5.9 0.235*
Chronic disease (n and %) 43 8.9 116 16.6 <0.001*
Apache II score          
 Mean and standard deviation 15.7 7.7 25.3 8.9 < 0.001†
 Median (Interquartile) 14 10-20 26 19-31 < 0.001‡
SOFA           
 Mean and standard deviation 4.1 3.0 8.1 3.5 < 0.001†
 Median (Interquartile) 3 2-6 8 6-10 < 0.001‡
28 days mortality (n and %) 101 21.0 396 56.8 < 0.001*
*Chi square test 
†Student’s t test
‡Mann-Whitney test
Table 2. ICU and hospital length of stay of survivor patients
               Variables                      Non-septic                              Septic  p-value
ICU length of stay (days)          
 Mean and standard deviation 2.9 2.2 14.3 17.6 < 0.001†
 Median (Interquartile) 2 2-3 8 4-18 < 0.001‡
Hospital length of stay (days)          
 Mean and standard deviation 19.9 15.2 36.0 27.8 < 0.001†
 Median (Interquartile) 15 9-27 27 16-48 < 0.001‡
† Student’s t test
‡ Mann-Whitney test
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patients (median = 3; IQ: 2-6) (p < 0.001). General char-
acteristics of patients in both groups are shown on Table 
1. APACHE II and SOFA scores were higher in non-sur-
vivors from both groups (data not shown). Kaplan–Mei-
er analysis of patients after 28 days of follow-up revealed 
survival probabilities of 79.0% and 43.2% for non-septic 
and septic patients, respectively (p < 0.001) (Figure 3).
preferentially admitted to larger hospitals. The incidence of 
sepsis was higher in medical ICU (17.2%) or mixed surgical-
medical ICU (15%) compared to surgical ICU (11.9%) 
(p = 0.005).
Other studies showed higher incidences of sepsis on ICU 
admission, which varied from 22.9% to 42%.7,19-23 Important 
multicentre studies that used epidemiological data from sev-
eral countries reported high variability in sepsis incidence, 
even between ICUs located in the same country. Possible 
explanations include difference in health care policies, hos-
pital characteristics, admission ICU criteria, and population 
characteristics. Albert and colleagues (2002) conducted a 
multicentre cohort study in 28 ICU from Europe, Canada, 
and Israel and observed variability in sepsis incidence that 
ranged from 1.5% in a Canadian ICU to 66.5% in a British 
ICU.20 A recent SOAP (Sepsis Occurrence in Acutely Ill Pa-
tients) study7 evaluated 198 ICU in 24 European countries 
and found similar variability with reports of 18% sepsis in-
cidence in Switzerland and 73% incidence in Portugal.
Results from our study compare favorably with data 
from Britain21,22 and other European countries.7 Similari-
ties between data from different studies are most likely due 
to the lack of ICU beds across different health systems. In 
Brazil, limitations on human resources and materials create 
the lack of ICU facilities, but in other countries, such as the 
United Kingdom, the lack of ICUs is more likely related to 
the political emphasis placed on primary health care. This 
highlights the potential impact of health care politics on in-
cidence of sepsis on admission to an ICU.
The BASES study (2004) identifi ed 31.8% (281/884) of 
patients admitted for more than 24 hours with sepsis on 
ICU admission,10 while we similarly detected sepsis in 47% 
(554/1179) of patients admitted to the ICU. Our incidence 
rate was higher than rates reported in other studies done in 
Brazil and other countries. Several factors may have contrib-
uted to our higher rate of incidence. Our hospital is a referee 
health service to a large region in southern Brazil, and our 
ICU is predominantly medical with a limited number of ICU 
beds.24 These characteristics are also associated with higher 
nosocomial infection rates,19,20,25 which could increase sepsis 
incidence during hospitalization. In support of this possi-
bility, Karlsson and colleagues26 found a lower incidence of 
sepsis in patients in the ICU (10.5%) in an institution in 
Finland that had a low frequency of multiresistant bacteria 
and is supported by a health system that allows early access 
to health care.
In addition to studying sepsis incidence at ICU admis-
sion, our study also evaluated the occurrence of sepsis dur-
ing patients’ stay in the ICU. We found a signifi cant increase 
in the number of sepsis cases with time spent in the ICU. Out 
of 697 patients classifi ed as septic, 554 (79.5%) fulfi lled di-
agnostic criteria on the fi rst day in the ICU and 143 (20.5%) 
developed diagnostic criteria in the subsequent days.
DISCUSSION
This study evaluated the incidence of sepsis in patients ad-
mitted to the ICU in a teaching hospital at Londrina, in the 
south of Brazil. This ICU has predominantly clinical admis-
sions with a high proportion of patients with sepsis diag-
nosis on admission, presenting with high severity of disease 
and mortality.
Across studies, the reported proportion of septic patients 
admitted to the ICU may vary according to study design, 
study population, and type of ICU, as well as public health 
strategies adopted locally. In our study, we only evaluated 
patients hospitalized in the ICU, but even when compared 
with similar populations of patients reported in literature, 
we observed a higher incidence of severe sepsis and septic 
shock among our patients upon admission.
In other countries, the incidence of sepsis ranged be-
tween 7.9 and 11.4% on ICU admission.16-18 A multicentre 
study18 evaluated sepsis epidemiologic data in France and 
reported a higher incidence of sepsis in teaching or regional 
hospitals (15.3%), and general hospitals (14.9%), compared 
to private hospitals (8.5%) (p < 0.008). Disease incidence 
was also higher in ICU patients in hospitals with more than 
400 beds (15.4%) compared to small hospitals (11.6%) 
(p = 0.016). These results suggested high risk patients are 
Sepsis epidemiology in a teaching hospital, Brazil
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Other Brazilian published data corroborated the increase 
in sepsis incidence we observed during ICU stay. The BASES 
study detected 281 (67.7%) sepsis cases on admission and 
another 134 (32.3%) cases during hospital stay,10 Recently, 
another study describing sepsis incidence in teaching hospi-
tals in South Brazil reported the occurrence of 31.9% sepsis 
cases, 24.5% severe sepsis cases and 31.4% septic shock cases 
during ICU stay.27
Methodological variations in epidemiologic studies 
make it diffi cult to compare results across studies. Even with 
the application of the same diagnostic criteria, there are var-
iations in study design, and inclusion and exclusion criteria, 
which probably account for some of the differences seen. 
However, in general, our results described a higher incidence 
of sepsis in ICU patients than reported in other studies, in-
cluding those from the Brazilian population.
Sepsis mortality is multifactorial and there are sev-
eral risk factors identifi ed in literature, including prognos-
tic scores,7,18,25 associated chronic diseases,28 acute organ 
dysfunction,3,7,18,25 alcoholism,29 age,2,4,7,25,30 and infection 
characteristics.7,23,25,28,31 Additionally, sepsis management ac-
cording to Surviving Sepsis Campaign can also change the 
disease prognosis and reduce patient mortality.32
Variability is high among epidemiological studies 
evaluating sepsis mortality. Here, we could not detect 
differences between mortality in patients with localized 
infection (35.7%) and sepsis (32.8%), possibly because 
less complicated clinical presentations of infection were 
observed in a population of critically ill patients, and pa-
tient deaths were not due to infection. Within a general 
population, infection and sepsis are usually associated 
with lower mortality rates. On the other hand, we de-
tected progressively increased mortality in cases of severe 
sepsis (49.9%) and septic shock (72.7%). Our results cor-
respond to those of Albert and colleagues (2003), who de-
scribed similar hospital mortality for localized infection 
(25.5%) and sepsis (25.5%), as well as increased mortality 
in patients with severe sepsis (40.9%) and septic shock 
(60.5%).28
When we compared the survival curve of septic patients 
and non-septic patients, we found a signifi cant difference 
in prognosis between these two groups of patients. Sepsis 
reduced early survival, evaluated at 28 days of follow-up. 
Although septic patients usually are older, male, and have 
associated chronic diseases, sepsis has been described as an 
independent risk factor for death by other authors.7,25,28,33
CONCLUSION
In conclusion, we observed a high incidence of sepsis and 
an increased mortality among sepsis patients in our study. 
The rates of sepsis incidence and mortality were higher in 
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